In this episode of the Long COVID Clinical Podcast, hosts Drs. Anita Chopra, Andrew Schamess, and Aaron Friedberg are joined by Dr. Michael Brode, medical director of the post-COVID-19 program at UT Health Austin, to discuss the complexities of long COVID management in the primary care setting. Dr. Brode explains how systemic inflammation and autoimmunity may contribute to symptoms like brain fog and fatigue. He highlights innovative research, including skin biopsies indicative of nerve damage in many patients, and discusses potential treatments like IVIG. Dr. Brode's insights provide a comprehensive view of long COVID as a systemic neuroimmunological disease, underscoring the need for targeted interventions and the potential for transformative patient outcomes.

Edited and Produced by Christopher Chiu and Carissa Lee

In this episode of the Long COVID Clinical Podcast, hosts Dr. Anita Chopra, Dr. Aaron Friedberg, and Carissa Lee are joined by Dr. Alba Azola, a rehabilitation physician and leading expert on long COVID at Johns Hopkins. Dr. Azola delves into the intricacies of autonomic nervous system dysregulation in long COVID and how it can manifest in diverse symptoms such as brain fog, POTS, and temperature dysregulation. The discussion explores innovative diagnostics and therapies, including blood-brain barrier studies and interventions like venous stenting. The episode offers insights into promising treatments, such as vagal nerve stimulation and IVIGs, and underscores the need for a nuanced, patient-centered approach to research and clinical management.

Edited and Produced by Christopher Chiu and Carissa Lee

In this episode of the Long COVID Clinical Podcast, hosted by Drs. Anita Chopra, Tiffany Walker, Andrew Schamess, and Aaron Friedberg, Dr. Michael Peluso shares groundbreaking insights into long COVID research. Dr. Peluso is an infectious disease physician and leader of the Long-term Impact of Infection with Novel Coronavirus (LIINC) study at UCSF. The discussion highlights the persistent presence of SARS-CoV-2 in the gut and immune system, revealing elevated immune activation in post-COVID patients and unexpected virus fragment locations. Dr. Peluso explores pivotal clinical trials with antivirals and monoclonal antibodies, emphasizing the need for better biomarkers and collaborative research efforts to accelerate diagnostics and therapies. His work aims to transform long COVID from a mysterious condition into a manageable illness, offering hope for millions affected.

Edited and Produced by Christopher Chiu and Carissa Lee